Although Aggrus was originally reported as a specific lymphatic endothelial marker protein called podoplanin, it is expressed by various malignant tumors, including squamous cell carcinomas, mesotheliomas, glioblastomas, and osteosarcomas [5, 8]. Here, PDPN is linked to cancer.